Educational Activities

Show Filters
Hide Filters
1-3 of 3 Activities
Title
Availability
Format
Credits
Course Opens
Buttons
On-Demand
Webinar
1.0
07/19/2022

Evolving Treatment Paradigms for Bladder Cancer: Expert Perspectives on the Latest Data

Bladder cancer thought leaders Drs. Sam Chang and Shilpa Gupta review the rapidly evolving bladder cancer treatment landscape across the full continuum of care, from emerging data in NMIBC, to novel neoadjuvant and adjuvant regimens in MIBC, to robust paradigmatic changes in locally advanced and mUC, both in the front-line setting and in subsequent lines of therapy.

1.0
07/19/2022

Sam S. Chang MD, MBA



Sam S. Chang MD, MBA

Professor, Department of Urology
Patricia and Rodes Hart Professor of Urologic Surgery
Chief Surgical Officer
Division of Urologic Oncology, Vanderbilt Ingram Cancer Center, Nashville, TN

Shilpa Gupta, MD

Director of the Genitourinary Medical Oncology
Cleveland Clinic
Co-Leader of the Genitourinary Oncology Program
Taussig Cancer Institute, Cleveland, OH

Shilpa Gupta, MD

Director of the Genitourinary Medical Oncology
Cleveland Clinic
Co-Leader of the Genitourinary Oncology Program
Taussig Cancer Institute, Cleveland, OH

Efficacy and Safety of Asparaginase-Containing Treatment Regimens in ALL/LBL and Beyond – An Interactive Review for Oncology Nurses and Nurse Practitioners

This CEC Oncology ONS Chapters Series is targeted to oncology nurses and advanced nurse practitioners serving as part of an interprofessional healthcare team providing care for pediatric and adult patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL).

1.0
03/14/2023

Sandra Kurtin, PhD, ANP-C, AOCN

Sandra Kurtin, PhD, ANP-C, AOCN

Live
Symposium
1.5
04/27/2024 at 6:00 PM EST

Guiding Light: Oncology Nurses’ Vital Role in Supporting Patients Through CLL Therapy

In this Creative Educational Concepts (CEC) live symposium, expert faculty will discuss strategies for differentiating patient- and disease-specific variables that inform CLL treatment selection, developing plans for managing new AEs, and addressing patient-related treatment barriers to improve adherence to CLL therapy.

1.5
04/27/2024 at 6:00 PM EST

Nikki Barkett, BSN, RN, OCN

Nikki Barkett, BSN, RN, OCN

Amy L. Goodrich, RN, BSN, MSN, CRNP-AC

Amy L. Goodrich, RN, BSN, MSN, CRNP-AC

Moderator

Matthew S. Davids, MD, MMSc

Matthew S. Davids, MD, MMSc